Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection

J Antimicrob Chemother. 2002 Nov;50(5):763-5. doi: 10.1093/jac/dkf204.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Adult
  • Alkynes
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Benzoxazines
  • Cyclopropanes
  • Female
  • HIV-1 / drug effects
  • Hepatitis, Viral, Human / complications
  • Hepatitis, Viral, Human / drug therapy
  • Hepatitis, Viral, Human / virology*
  • Humans
  • Liver Failure / chemically induced*
  • Liver Failure / physiopathology
  • Oxazines / adverse effects*

Substances

  • Alkynes
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • efavirenz